FDA Approves Afternoon-After Pill
INTERCOURSE, PA - “Let’s face it: no one is getting up in the morning after an accident,” said a representative from the Food and Drug Administration...
FDA approves first novel drug to treat medical burnout
TWISP, WA - The US Food and Drug Administration today approved Peaceaudi (Idongivafumab) injection for intravenous use for the treatment of medical burnout.
“Medical burnout...
Hospital Debuts Combination Clinic/Pharmacy Drive-Thru
RALEIGH, NC - A brand new healthcare system opened in Raleigh last week, as Atlantic Healthcare System (AHS) unveiled its state-of-the-art drive-thru clinic/pharmacy to rave...
Pharmacists Reassure Worried Public They’ll Never Run Out of GoLytely
BRAINTREE, MA—From antibiotics to analgesics and anesthetics to ACLS drugs, there is an underreported epidemic of drug shortages in America. With over 140 vital...
Staph Aureus Bacterium Ridiculed by for Still Being Sensitive to Methicillin
A single, sad Staph Aureus bacterium has been shunned from its colony for still being sensitive to methicillin in the year 2019.
“Apparently it didn’t...
Unsure What’s a Banana Bag, Pharmacist Just Bags a Bunch of Bananas
HONOLULU, HI - New pharmacist Aaron Prior-Auth admits he was flustered when nurse practitioner Karen Kaufmann called him up to get a "banana bag,...
So Your Patient Is Allergic to Benadryl? Diphenhydramine Might Be the Answer
One might think it counter intuitive to re-administer a known allergen to a patient, especially if they are in the throws of an allergic...
A Pharmacist’s Nightmare: A Drug Seeker & Their Excuses
We all know that pharmacists and pharmacy technicians are on the front lines when it comes to drug-seeking patients. Somehow they can hold it...
Neurologists Recommend Gas-X for Treatment of Brain Farts
MINNEAPOLIS, MN - The American Academy of Neurology (AAN) has updated their guidelines for the diagnosis and management of brain farts, a condition characterized...
Cancer Drug Delayed 2 Years Due to Licensing Deal
Boston, MA – Astra-Nomical has delayed their wonder cancer drug, Fizamax (ferazepatab), again. This time up to 2 years because of promotional disputes.
“We were...